See more : Minera IRL Limited (MIRL.CN) Income Statement Analysis – Financial Results
Complete financial analysis of International Flavors & Fragrances Inc. (IFF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of International Flavors & Fragrances Inc., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
You may be interested
- Grindr Inc. WT (GRND-WT) Income Statement Analysis – Financial Results
- Gfinity plc (GFIN.L) Income Statement Analysis – Financial Results
- Good Finance Securities Co., Ltd. (6021.TWO) Income Statement Analysis – Financial Results
- Kula Gold Limited (KGD.AX) Income Statement Analysis – Financial Results
- Inversa Prime SOCIMI, S.A. (YIPS.MC) Income Statement Analysis – Financial Results
International Flavors & Fragrances Inc. (IFF)
About International Flavors & Fragrances Inc.
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through Nourish, Scent, Health & Biosciences, and Pharma Solutions segments. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds, and savory solutions and inclusions. It also provides natural food protection ingredients consist of natural antioxidants and anti-microbials as well as beverages, sweets , and dairy products. The Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that could be combined with other materials to create fragrance and consumer compounds; and cosmetic active ingredients consisting of active and functional ingredients, botanicals, and delivery systems to support its customers' cosmetic and personal care product lines. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients. The Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products. International Flavors & Fragrances Inc. was founded in 1833 and is headquartered in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.48B | 12.44B | 11.66B | 5.08B | 5.14B | 3.98B | 3.40B | 3.12B | 3.02B | 3.09B | 2.95B | 2.82B | 2.79B | 2.62B | 2.33B | 2.39B | 2.28B | 2.10B | 1.99B | 2.03B | 1.90B | 1.81B | 1.84B | 1.46B | 1.44B | 1.41B | 1.43B | 1.44B | 1.44B | 1.32B | 1.19B | 1.13B | 1.02B | 962.80M | 869.50M | 839.50M | 745.90M | 620.70M | 501.00M |
| Cost of Revenue | 7.80B | 8.29B | 7.92B | 3.00B | 3.03B | 2.29B | 1.92B | 1.72B | 1.67B | 1.73B | 1.67B | 1.65B | 1.68B | 1.53B | 1.39B | 1.42B | 1.32B | 1.21B | 1.17B | 1.16B | 1.09B | 1.04B | 1.06B | 762.31M | 735.40M | 714.50M | 722.90M | 731.00M | 706.30M | 641.40M | 578.70M | 548.00M | 498.50M | 474.60M | 433.00M | 414.10M | 372.60M | 311.00M | 245.90M |
| Gross Profit | 3.68B | 4.15B | 3.74B | 2.09B | 2.11B | 1.68B | 1.48B | 1.40B | 1.35B | 1.36B | 1.28B | 1.18B | 1.10B | 1.09B | 935.13M | 970.63M | 952.21M | 884.13M | 824.40M | 873.42M | 809.06M | 773.41M | 780.33M | 700.49M | 704.10M | 692.80M | 703.90M | 705.10M | 733.20M | 673.80M | 609.90M | 578.40M | 518.50M | 488.20M | 436.50M | 425.40M | 373.30M | 309.70M | 255.10M |
| Gross Profit Ratio | 32.07% | 33.37% | 32.04% | 41.03% | 41.10% | 42.31% | 43.52% | 44.89% | 44.71% | 44.10% | 43.49% | 41.66% | 39.62% | 41.66% | 40.20% | 40.62% | 41.83% | 42.19% | 41.36% | 42.95% | 42.55% | 42.75% | 42.32% | 47.89% | 48.91% | 49.23% | 49.33% | 49.10% | 50.93% | 51.23% | 51.31% | 51.35% | 50.98% | 50.71% | 50.20% | 50.67% | 50.05% | 49.90% | 50.92% |
| Research & Development | 636.00M | 603.00M | 629.00M | 356.86M | 346.13M | 311.58M | 286.03M | 254.26M | 246.10M | 253.64M | 259.84M | 233.71M | 219.78M | 218.77M | 193.84M | 212.70M | 199.02M | 185.69M | 179.81M | 175.17M | 159.29M | 144.03M | 135.25M | 112.67M | 103.80M | 98.40M | 94.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 707.46M | 557.31M | 566.22M | 509.56M | 514.89M | 505.88M | 453.54M | 443.97M | 447.39M | 376.54M | 381.84M | 375.29M | 351.92M | 339.32M | 341.31M | 308.95M | 305.16M | 313.34M | 258.65M | 262.60M | 238.70M | 227.10M | 317.00M | 308.50M | 288.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.53M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.79B | 1.77B | 1.75B | 948.83M | 876.12M | 707.46M | 557.31M | 566.22M | 520.09M | 514.89M | 505.88M | 453.54M | 443.97M | 447.39M | 376.54M | 381.84M | 375.29M | 351.92M | 339.32M | 341.31M | 308.95M | 305.16M | 313.34M | 258.65M | 262.60M | 238.70M | 227.10M | 317.00M | 308.50M | 288.80M | 268.90M | 280.80M | 234.80M | 220.70M | 198.10M | 191.80M | 173.70M | 151.40M | 125.70M |
| Other Expenses | 0.00 | 727.00M | 732.00M | 192.61M | 193.10M | 35.24M | 20.97M | 9.35M | -3.18M | 2.81M | 15.64M | -1.45M | 0.00 | 0.00 | 6.15M | 6.15M | 12.88M | 14.84M | 15.07M | 14.83M | 12.63M | 12.63M | 46.09M | 69.34M | 56.40M | 49.00M | 50.30M | 47.80M | 40.70M | 36.40M | 35.10M | 34.00M | 29.40M | 28.20M | 24.30M | 22.70M | 20.70M | 18.40M | 14.60M |
| Operating Expenses | 5.79B | 3.10B | 3.11B | 1.50B | 1.42B | 1.09B | 878.03M | 844.25M | 766.19M | 768.53M | 765.72M | 687.25M | 663.76M | 666.16M | 576.54M | 600.69M | 587.19M | 552.46M | 534.21M | 531.31M | 480.87M | 461.82M | 494.67M | 440.67M | 422.80M | 386.10M | 371.80M | 364.80M | 349.20M | 325.20M | 304.00M | 314.80M | 264.20M | 248.90M | 222.40M | 214.50M | 194.40M | 169.80M | 140.30M |
| Cost & Expenses | 13.62B | 11.39B | 11.03B | 4.50B | 4.44B | 3.39B | 2.80B | 2.56B | 2.44B | 2.49B | 2.43B | 2.33B | 2.35B | 2.20B | 1.97B | 2.02B | 1.91B | 1.76B | 1.70B | 1.69B | 1.57B | 1.50B | 1.56B | 1.20B | 1.16B | 1.10B | 1.09B | 1.10B | 1.06B | 966.60M | 882.70M | 862.80M | 762.70M | 723.50M | 655.40M | 628.60M | 567.00M | 480.80M | 386.20M |
| Interest Income | 0.00 | 336.00M | 289.00M | 132.00M | 138.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 380.00M | 336.00M | 289.00M | 131.80M | 138.22M | 132.56M | 65.36M | 52.99M | 46.06M | 46.07M | 46.77M | 41.75M | 44.64M | 48.71M | 61.82M | 74.01M | 41.54M | 25.55M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.14B | 1.18B | 1.16B | 325.36M | 323.33M | 173.79M | 117.97M | 102.47M | 89.60M | 89.35M | 83.23M | 76.67M | 75.33M | 79.24M | 78.53M | 75.99M | 82.79M | 89.73M | 91.93M | 91.00M | 86.72M | 84.46M | 123.49M | 69.34M | 56.40M | 49.00M | 50.30M | 47.80M | 40.70M | 36.40M | 35.10M | 34.00M | 29.40M | 28.20M | 24.30M | 22.70M | 20.70M | 18.40M | 14.60M |
| EBITDA | -996.00M | -110.00M | 1.80B | 897.68M | 1.02B | 753.60M | 719.59M | 678.58M | 674.76M | 684.21M | 615.00M | 561.84M | 493.51M | 487.54M | 412.89M | 430.52M | 442.62M | 428.56M | 402.17M | 470.21M | 414.92M | 396.06M | 409.15M | 329.16M | 337.70M | 355.75M | 382.40M | 388.10M | 424.70M | 385.00M | 341.00M | 297.60M | 283.70M | 267.50M | 238.40M | 233.60M | 199.60M | 158.30M | 129.40M |
| EBITDA Ratio | -8.68% | 18.24% | 15.78% | 18.09% | 20.45% | 20.03% | 21.77% | 21.39% | 22.22% | 22.20% | 20.91% | 19.97% | 18.52% | 19.28% | 18.79% | 18.78% | 19.44% | 19.77% | 20.18% | 23.12% | 24.34% | 22.34% | 23.68% | 25.96% | 25.72% | 24.82% | 26.07% | 29.69% | 28.61% | 27.36% | 25.74% | 23.73% | 25.46% | 24.17% | 25.52% | 27.05% | 25.93% | 25.00% | 24.93% |
| Operating Income | -2.11B | 1.09B | 585.00M | 566.48M | 665.27M | 583.88M | 581.44M | 567.36M | 577.82M | 592.32M | 518.49M | 488.29M | 440.90M | 416.36M | 358.59M | 351.73M | 365.03M | 328.99M | 266.88M | 310.28M | 285.77M | 311.60M | 285.66M | 259.82M | 281.30M | 306.70M | 332.10M | 340.30M | 384.00M | 348.60M | 305.90M | 263.60M | 254.30M | 239.30M | 214.10M | 210.90M | 178.90M | 139.90M | 114.80M |
| Operating Income Ratio | -18.38% | 8.76% | 5.02% | 11.14% | 12.94% | 14.68% | 17.11% | 18.21% | 19.11% | 19.18% | 17.56% | 17.31% | 15.81% | 15.87% | 15.42% | 14.72% | 16.03% | 15.70% | 13.39% | 15.26% | 15.03% | 17.22% | 15.49% | 17.76% | 19.54% | 21.79% | 23.28% | 23.70% | 26.68% | 26.51% | 25.74% | 23.40% | 25.00% | 24.85% | 24.62% | 25.12% | 23.98% | 22.54% | 22.91% |
| Total Other Income/Expenses | -408.00M | -299.00M | -231.00M | -125.11M | -157.55M | -136.13M | -100.26M | -43.64M | -49.25M | -43.26M | -55.06M | -44.87M | -67.36M | -67.06M | -63.74M | -91.42M | -36.34M | -15.39M | -44.01M | -61.11M | -33.91M | -45.18M | -97.88M | -75.69M | -37.80M | 4.40M | 8.10M | -41.20M | 9.70M | 11.70M | 17.90M | 17.90M | 15.20M | 12.80M | 9.00M | -1.60M | -3.50M | -600.00K | -2.20M |
| Income Before Tax | -2.52B | -1.63B | 354.00M | 441.37M | 557.45M | 447.76M | 537.05M | 523.72M | 528.57M | 549.06M | 485.21M | 443.42M | 373.55M | 359.59M | 276.55M | 280.52M | 328.68M | 313.28M | 246.19M | 281.00M | 251.86M | 266.42M | 187.78M | 184.13M | 243.50M | 311.10M | 340.20M | 299.10M | 393.70M | 360.30M | 323.80M | 281.50M | 269.50M | 252.10M | 223.10M | 209.30M | 175.40M | 139.30M | 112.60M |
| Income Before Tax Ratio | -21.94% | -13.06% | 3.04% | 8.68% | 10.85% | 11.26% | 15.80% | 16.81% | 17.48% | 17.78% | 16.43% | 15.72% | 13.40% | 13.71% | 11.89% | 11.74% | 14.44% | 14.95% | 12.35% | 13.82% | 13.25% | 14.73% | 10.18% | 12.59% | 16.92% | 22.11% | 23.84% | 20.83% | 27.35% | 27.40% | 27.24% | 24.99% | 26.50% | 26.18% | 25.66% | 24.93% | 23.52% | 22.44% | 22.48% |
| Income Tax Expense | 45.00M | 211.00M | 75.00M | 74.00M | 97.18M | 107.98M | 241.38M | 118.69M | 116.91M | 134.52M | 131.67M | 189.28M | 106.68M | 96.04M | 81.02M | 50.89M | 81.56M | 86.78M | 53.12M | 84.93M | 79.26M | 90.47M | 71.78M | 61.12M | 81.50M | 107.30M | 122.00M | 109.20M | 144.90M | 134.30M | 121.30M | 104.80M | 100.80M | 95.40M | 84.50M | 80.60M | 68.40M | 53.60M | 42.90M |
| Net Income | -2.57B | -1.84B | 268.00M | 365.00M | 455.87M | 337.30M | 295.67M | 405.03M | 411.67M | 414.54M | 353.54M | 254.13M | 266.87M | 263.56M | 195.53M | 229.63M | 247.13M | 226.50M | 193.07M | 196.07M | 172.60M | 175.94M | 116.00M | 123.01M | 162.00M | 203.80M | 218.20M | 189.90M | 248.80M | 226.00M | 202.50M | 170.60M | 168.70M | 156.70M | 138.60M | 128.70M | 107.00M | 85.70M | 69.70M |
| Net Income Ratio | -22.35% | -14.76% | 2.30% | 7.18% | 8.87% | 8.48% | 8.70% | 13.00% | 13.62% | 13.42% | 11.97% | 9.01% | 9.57% | 10.05% | 8.41% | 9.61% | 10.85% | 10.81% | 9.69% | 9.64% | 9.08% | 9.72% | 6.29% | 8.41% | 11.25% | 14.48% | 15.29% | 13.22% | 17.28% | 17.18% | 17.04% | 15.15% | 16.59% | 16.28% | 15.94% | 15.33% | 14.35% | 13.81% | 13.91% |
| EPS | -10.06 | -7.20 | 1.10 | 3.25 | 4.04 | 3.85 | 3.73 | 5.07 | 5.19 | 5.09 | 4.32 | 3.11 | 3.30 | 3.29 | 2.48 | 2.89 | 2.86 | 2.50 | 2.06 | 2.08 | 1.84 | 1.86 | 1.21 | 1.22 | 1.53 | 1.90 | 2.00 | 1.71 | 2.24 | 2.03 | 1.78 | 1.48 | 1.47 | 1.37 | 1.22 | 1.13 | 0.94 | 0.76 | 0.63 |
| EPS Diluted | -10.06 | -7.20 | 1.10 | 3.20 | 4.00 | 3.83 | 3.72 | 5.05 | 5.16 | 5.06 | 4.29 | 3.09 | 3.26 | 3.26 | 2.46 | 2.86 | 2.82 | 2.48 | 2.04 | 2.05 | 1.83 | 1.84 | 1.20 | 1.22 | 1.53 | 1.90 | 1.99 | 1.70 | 2.24 | 2.03 | 1.77 | 1.48 | 1.47 | 1.37 | 1.22 | 1.13 | 0.94 | 0.76 | 0.63 |
| Weighted Avg Shares Out | 255.00M | 255.00M | 243.00M | 112.16M | 111.97M | 87.55M | 79.07M | 79.65M | 80.45M | 80.94M | 81.32M | 81.11M | 80.46M | 79.50M | 78.40M | 79.03M | 86.54M | 90.60M | 93.72M | 94.26M | 93.80M | 94.59M | 95.87M | 100.82M | 105.88M | 107.26M | 109.10M | 111.05M | 111.07M | 111.33M | 113.76M | 115.27M | 114.76M | 114.38M | 113.61M | 113.89M | 113.83M | 112.76M | 110.63M |
| Weighted Avg Shares Out (Dil) | 255.00M | 255.00M | 243.00M | 113.63M | 113.31M | 88.12M | 79.37M | 79.98M | 80.89M | 81.49M | 81.93M | 81.83M | 81.47M | 80.44M | 79.09M | 79.72M | 87.63M | 91.33M | 94.64M | 95.64M | 94.32M | 95.62M | 96.67M | 100.82M | 105.88M | 107.26M | 109.65M | 111.71M | 111.17M | 111.46M | 114.41M | 115.27M | 114.76M | 114.38M | 113.61M | 113.89M | 113.83M | 112.76M | 110.63M |
Hidden gems: 3 undervalued stocks with a unique competitive edge
Companies with unique competitive advantages aren't always rewarded by the market: Etsy Inc. NASADQ: ETSY, International Flavors & Fragrances Inc. NYSE: IFF and Zimmer Biomet Holdings Inc. NYSE: ZBH are examples of stocks that appear to be trading well below...
Tax-loss selling makes these stocks in cannabis, pharma, energy and industrials worth buying
In an annual year-end ritual, investors have dumped many of their stock losers to offset taxable gains. This so-called “tax loss selling” can create buying opportunities in promising names.
International Flavors (IFF) Expands Collaboration With Kemira
International Flavors (IFF) and Kemira are set to commercialize newly designed enzymatic biomaterials.
3 Vulnerable Retail Stocks That Won't Survive the Holidays
The holiday sales season tends to be a “make or break” window for retail stocks. Many companies inch along throughout the year, posting similar stats quarter over quarter (QOQ).
International Flavors (IFF) Up 5.4% Since Last Earnings Report: Can It Continue?
International Flavors (IFF) reported earnings 30 days ago. What's next for the stock?
International Flavors (IFF) Q3 Earnings Beat Estimates, Decline Y/Y
International Flavors' (IFF) Q3 earnings fall year over year as lower volumes offset the impact of higher pricing and productivity gains.
International Flavors (IFF) Q3 Earnings and Revenues Beat Estimates
International Flavors (IFF) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of $0.76 per share. This compares to earnings of $1.36 per share a year ago.
Compared to Estimates, International Flavors (IFF) Q3 Earnings: A Look at Key Metrics
The headline numbers for International Flavors (IFF) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
IFF Reports Third Quarter 2023 Results
NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE: IFF) reported financial results for the third quarter ended September 30, 2023. Third Quarter 2023 Consolidated Summary: Reported (GAAP) Adjusted (Non-GAAP)1 Sales Income Before Taxes EPS Operating EBITDA Operating EBITDA...
IFF Announces Continuation of Cooperation Agreement with Icahn Capital
NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE: IFF) today announced the continuation of the cooperation agreement with Icahn Capital LP and its affiliates. Icahn Capital and IFF have agreed to renominate one Icahn director and one mutually agreed director to the IFF...
Source: https://incomestatements.info
Category: Stock Reports